Selinexor (KPT-330)

Selinexor (KPT-330)
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T6106-2mg 2 mg

7 - 10 business days*

40.00€
TGM-T6106-5mg 5 mg

7 - 10 business days*

74.00€
TGM-T6106-25mg 25 mg

7 - 10 business days*

280.00€
TGM-T6106-50mg 50 mg

7 - 10 business days*

420.00€
TGM-T6106-100mg 100 mg

7 - 10 business days*

480.00€
 
Description: Selinexor (KPT-330) is a small molecule inhibitor of CRM1 with selective and oral... more
Product information "Selinexor (KPT-330)"
Description: Selinexor (KPT-330) is a small molecule inhibitor of CRM1 with selective and oral activity. Selinexor blocks the cell cycle, induces apoptosis, and has antitumor activity for the treatment of multiple myeloma. Target: CRM1. Smiles: FC(F)(F)c1cc(cc(c1)C(F)(F)F)-c1ncn(\C=C/C(=O)NNc2cnccn2)n1. References: Etchin J, et al. KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Br J Haematol. 2013 Apr,161(1):117-27.
Keywords: KPT-330, Selinexor
Supplier: TargetMol
Supplier-Nr: T6106

Properties

Application: Targets exportin-1 (XPO1, CRM1)
MW: 443.31 D
Formula: C17H11F6N7O
Format: 32160405

Database Information

CAS : 1393477-72-9| Matching products
KEGG ID : K14290 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Selinexor (KPT-330)"
Write a review
or to review a product.
Viewed